Spitalfields Estate Company Limited

(Registration number: 03542612)
Balance Sheet as at 5 April 2026

	Note	2026 £	2025 £
Fixed assets
Tangible assets	4	859,497	853,892
Current assets
Stocks	5	2,000	2,000
Debtors	6	5,805	3,696
Cash at bank and in hand		7,822	12,249
		15,627	17,945
Creditors: Amounts falling due within one year	7	(430,005)	(368,549)
Net current liabilities		(414,378)	(350,604)
Net assets		445,119	503,288
Capital and reserves
Called up share capital	8	400,002	400,002
Retained earnings		45,117	103,286
Shareholders' funds		445,119	503,288

For the financial year ending 5 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Spitalfields Estate Company Limited

(Registration number: 03542612)
Balance Sheet as at 5 April 2026
(continued)

Approved and authorised by the director on 30 October 2026
 

......................................... Mr S J J Wedgwood Director

Spitalfields Estate Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026

1	General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
18 Princelet Street
London
E1 6QH
England

The principal place of business is:
Manor House Farm
Abdon
Craven Arms
SY7 9HZ

These financial statements were authorised for issue by the director on 30 October 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Spitalfields Estate Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026
(continued)

2	Accounting policies (continued)

Revenue recognition

Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when goods are delivered and legal title has passed.

Tax

Taxation represents the sum of tax currently payable and deferred tax.

The company's liability for current tax is calculated using tax rates that have been enacted or substantially enacted by the end of the reporting period.

Deferred tax is recognised on all timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantially enacted by the end of the reporting period.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Freehold land	Nil
Plant and machinery	15% of cost per annum
Computer equipment	33.3% of cost per annum
Fixtures & fittings	20% of cost per annum

Spitalfields Estate Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026
(continued)

2	Accounting policies (continued)

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit and loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.

When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2025 - 1).

Spitalfields Estate Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026
(continued)

4	Tangible assets

	Land and buildings £	Furniture, fittings and equipment  £	Total £
Cost or valuation
At 6 April 2025	846,536	37,825	884,361
Additions	6,305	2,361	8,666
At 5 April 2026	852,841	40,186	893,027
Depreciation
At 6 April 2025	-	30,469	30,469
Charge for the year	-	3,061	3,061
At 5 April 2026	-	33,530	33,530
Carrying amount
At 5 April 2026	852,841	6,656	859,497
At 5 April 2025	846,536	7,356	853,892

Included within the net book value of land and buildings above is £852,841 (2025 - £846,536) in respect of freehold land and buildings.
 

5

Stocks

	2026 £	2025 £
Other inventories	2,000	2,000

Spitalfields Estate Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026
(continued)

6

Debtors

Current	2026 £	2025 £
Prepayments	5,805	3,696
	5,805	3,696

7

Creditors

Creditors: amounts falling due within one year

	Note	2026 £	2025 £
Due within one year
Trade creditors		9,506	5,310
Amounts owed to group undertakings and undertakings in which the company has a participating interest		418,204	358,204
Accruals and deferred income		2,172	1,302
Other creditors		123	3,733
		430,005	368,549

Spitalfields Estate Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026
(continued)

8	Share capital

Allotted, called up and fully paid shares

	2026		2025
	No.	£	No.	£
Ordinary shares of £1 each	400,002	400,002	400,002	400,002

9	Parent and ultimate parent undertaking

The company's immediate parent is Abdon Holdings Limited, incorporated in England.

 The ultimate controlling party is S J J Wedgwood Esq.